Clarius Mobile Health

Overview
Activities
News
Next-gen Medical Devices?
Product stageSegments
Go-to-Market
?
Diagnostic devices
?

Clarius Mobile Health is a Vancouver-based medical technology company that develops and manufactures high-performance handheld wireless ultrasound scanners. Founded by experienced innovators in the ultrasound industry, Clarius aims to make accurate, easy-to-use, and affordable ultrasound tools available to medical professionals across all specialties. The company's product line consists of pocket-sized scanners that wirelessly connect to iOS and Android devices through an AI-powered application. Clarius scanners utilize octal beamforming technology, delivering up to eight times faster frame rates and micron-level resolution compared to other handheld devices. As of July 2023, over 20,000 clinicians had used Clarius scanners, performing more than 3.8 million scans. The company offers ten AI-powered models of handheld ultrasound scanners designed for various medical specialties, including orthopedic surgeons, aesthetic clinicians, emergency physicians, and veterinarians. In January 2022, Clarius introduced its third-generation product line, which was 30% lighter and smaller than previous models. The scanners are built with the latest antenna technology for reliable connectivity and are compatible with both iOS and Android devices. Clarius employs over 150 people at its headquarters, innovation center, and manufacturing facility in Vancouver, British Columbia.

Key customers and partnerships

Clarius scanners are used in more than 90 countries worldwide. The company has partnered with the Digital Technology Supercluster, a federally funded organization in Canada, to deliver its portable handheld ultrasound scanners to rural doctors across British Columbia. As part of the Supercluster's 'Intelligent Network for Point-of-Care Ultrasound' project, Clarius worked with a consortium of partners led by Providence healthcare to provide scanners to healthcare practitioners in rural and Indigenous communities across B.C. for detecting pneumonia in suspected Covid-19 patients. In July 2023, Clarius was selected by the Government of Canada to participate in the Global Hypergrowth Project, a program designed to support the country's most promising scale-up companies in their growth efforts.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
2985 Virtual Way #130 Vancouver BC CAN
Founded year:
2014
Employees:
101-250
IPO status:
Private
Total funding:
USD 13.8 mn
Last Funding:
USD 2.5 mn (Grant; Mar 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.